Mayo Clinic
Rochester, Minnesota, 55905, United States
NCT Number: NCT01300338
Does home telemonitoring increase the number of diabetes patients at goal blood pressure in a primary care practice?
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
This is a randomized control trial, two arms with block randomization. Primary care patients with diabetes and elevated blood pressure randomized to intervention or control. Intervention arm: home telemonitoring using the Ideal Life blood pressure cuff and telephone or internet transmission device to transmit blood pressure information to the Primary care manager team with otherwise normal care manager care. Control arm: Omron (off the shelf) home blood pressure monitor (no transmission of data) and usual care. We will be comparing blood pressure control between groups and provider contacts.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood pressure monitor for home use with readings uploaded to a web server viewable by the diabetes care manager
Other names: Ideal Life Blood Pressure Monitor
Self monitor of blood pressure without telemetry
Other names: Omron blood pressure monitor
Time frame: Baseline, 6 months
Average change in systolic blood pressure (top number of blood pressure reading) from baseline to 6 months.
Time frame: Baseline, 6 months
Average change in diastolic blood pressure (bottom number of blood pressure reading) from baseline to 6 months.
Mayo Clinic
Other
Does Home Telemonitoring Increase the Number of Diabetic Patients at Goal Blood Pressure in a Primary Care Practice?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsNCT05565716
Cardiovascular Diseases, Chronic Disease
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07532564
Anemia, Anemia, Hemolytic
Baltimore, Maryland, United States
View Trial DetailsNCT04286555
Cardiovascular Diseases, Diabetes
Baltimore, Maryland, United States
View Trial Details